These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7770384)

  • 21. [Diagnosis and therapy: autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis].
    Strassburg CP
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S202-4. PubMed ID: 16435709
    [No Abstract]   [Full Text] [Related]  

  • 22. Sclerosing cholangitis.
    MacFaul GR; Chapman RW
    Curr Opin Gastroenterol; 2006 May; 22(3):288-93. PubMed ID: 16550044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone disorders in cholestatic liver diseases.
    Isaia G; Di Stefano M; Roggia C; Ardissone P; Rosina F
    Forum (Genova); 1998; 8(1):28-38. PubMed ID: 9514992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diet in liver diseases].
    Strohmeyer G
    Z Allgemeinmed; 1974 Jan; 50(2):50-2. PubMed ID: 4816783
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of diseases of the liver.
    Berris B
    Appl Ther; 1968 Apr; 10(4):262-4. PubMed ID: 5655423
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy of chronic liver diseases].
    Geisenhainer G
    Z Arztl Fortbild (Jena); 1972 Dec; 66(23):1199-201. PubMed ID: 4652157
    [No Abstract]   [Full Text] [Related]  

  • 27. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary sclerosing cholangitis.
    Geonzon-Gonzales MR
    Gastroenterol Nurs; 2007; 30(2):102-5; quiz 105-7. PubMed ID: 17440311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diet therapy of chronic liver diseases with special reference to protein requirements].
    Vetter K; Kaschube I; Aust L
    Dtsch Gesundheitsw; 1969 Dec; 24(52):2459-65. PubMed ID: 5375929
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diagnosis and therapy of primary biliary cirrhosis and primary sclerosing cholangitis].
    Strassburg CP; Manns MP
    Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S96-8. PubMed ID: 12817335
    [No Abstract]   [Full Text] [Related]  

  • 31. Guidelines for therapy of autoimmune liver disease.
    Ishibashi H; Komori A; Shimoda S; Gershwin ME
    Semin Liver Dis; 2007 May; 27(2):214-26. PubMed ID: 17520519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Enteral nutrition for liver failure].
    Hayashi S; Watanabe A; Nagashima H
    Nihon Rinsho; 1982; 40(4):824-30. PubMed ID: 6808197
    [No Abstract]   [Full Text] [Related]  

  • 33. Review article: current management of primary sclerosing cholangitis.
    Cullen SN; Chapman RW
    Aliment Pharmacol Ther; 2005 Apr; 21(8):933-48. PubMed ID: 15813829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of alcoholic liver disease.
    Lucey MR
    Clin Liver Dis; 2009 May; 13(2):267-75. PubMed ID: 19442918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathophysiologic, pathomorphologic and clinical principles of a rational liver therapy].
    Franken FH
    Hippokrates; 1971 Mar; 42(1):25-39. PubMed ID: 5550582
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hyperbaric oxygen therapy for hepatic insufficiency (compared with other current methods of treatment)].
    Ohresser P; Sahel J; Girbal JP; Gauthier A
    Mars Med; 1969; 106(4):313-9. PubMed ID: 5383413
    [No Abstract]   [Full Text] [Related]  

  • 37. Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence.
    Seyam M; Neuberger JM; Gunson BK; Hübscher SG
    Liver Transpl; 2007 Jul; 13(7):966-74. PubMed ID: 17370332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins.
    Farges O; Saliba F; Farhamant H; Samuel D; Bismuth A; Reynes M; Bismuth H
    Hepatology; 1996 Feb; 23(2):240-8. PubMed ID: 8591847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
    Malik SM; Ahmad J
    Liver Transpl; 2010 Apr; 16(4):533. PubMed ID: 20373463
    [No Abstract]   [Full Text] [Related]  

  • 40. Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groups.
    Longworth L; Young T; Buxton MJ; Ratcliffe J; Neuberger J; Burroughs A; Bryan S;
    Liver Transpl; 2003 Dec; 9(12):1295-307. PubMed ID: 14625830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.